Skip to main content
. 2023 Oct 30;14:1282824. doi: 10.3389/fgene.2023.1282824

TABLE 1.

Patient characteristics in TCGA cases with each metabolic subtype phenotype.

Characteristics PDAC tumor metabolic subtypes p-value
M1 (Lower-risk) No (n = 104) (%) M2 (High-risk) No (n = 38) (%)
Age (years) 0.440
 Mean ± SD 64.54 ± 10.633 66.58 ± 10.892
Sex 0.684
 Female 48 (46.2) 19 (50.0)
 Male 56 (53.8) 19 (50.0)
Race 0.761
 Asian 5 (5.0) 3 (7.9)
 African American 4 (4.0) 1 (2.6)
 White 91 (91.0) 34 (89.5)
Histologic Grade 0.219
 G1 16 (15.4) 4 (10.5)
 G2 60 (57.7) 19 (50.0)
 G3 28 (26.9) 14 (36.8)
 G4 0 (0.0) 1 (2.6)
Tumour Stage 0.717
 T1 2 (1.9) 1 (2.7)
 T2 13 (12.5) 3 (8.1)
 T3 87 (83.7) 33 (89.2)
 T4 2 (1.9) 0 (0.0)
Lymph Node Stage 0.459
 N0 28 (27.2) 8 (21.1)
 N1 75 (72.8) 30 (78.9)
Metastatic Stage 0.871
 M0 47 (94.0) 19 (95.0)
 M1 3 (6.0) 1 (5.0)
Smoking History Category 0.538
 1 33 (38.8) 17 (51.5)
 2 12 (14.1) 5 (15.2)
 3 21 (24.7) 4 (12.1)
 4 14 (16.5) 6 (18.2)
 5 5 (5.9) 1 (3.0)
Alcohol History 0.830
 No 37 (38.1) 13 (36.1)
 Yes 60 (61.9) 23 (63.9)
Diabetes History 0.270
 No 61 (70.9) 29 (80.6)
 Yes 25 (29.1) 7 (19.4)
HHS Vulnerability Disclosure